Further to an earlier posting about Merck and Elsevier combining on a fake journal, Elsevier now acknowledges that there were six "sponsored article publications."
Elsevier Published Six Fake Journals
2 Comments
Recent Posts
When Writing About Antisemitism Proves the Point: What the Replies Reveal 
Acting on Antisemitism: If This Was Always Possible, Why Didn’t It Happen Sooner? 
Setting Canada’s AI Policy Priorities: My Appearance Before the Standing Committee on Industry, Science and Technology 
The Law Bytes Podcast, Episode 262: Zack Shapiro on the Claude AI Native Law Firm 
The Online Streaming Act in Jeopardy: U.S. Takes Aim at the CUSMA Cultural Exemption With Threats of Bill C-11 Retaliation
Use bugmenot to read the article
If you do not want to register just to read an article, use bugmenot.com to enter the-scientist site.
Sick and tired of walled gardens like Elsevier? Support Science Commons
http://sciencecommons.org/about/
Quote:
There are petabytes of research data being produced in laboratories around the world, but the best web search tools available can’t help us make sense of it. Why? Because more stands between basic research and meaningful discovery than the problem of search.
Many scientists today work in relative isolation, left to follow blind alleys and duplicate existing research. Data are balkanized — trapped behind firewalls, locked up by contracts or lost in databases that can’t be accessed or integrated. Materials are hard to get — universities are overwhelmed with transfer requests that ought to be routine, while grant cycles pass and windows of opportunity close. It’s not uncommon for research sponsors to invest hundreds of millions of dollars in critically important efforts like drug discovery, only to see them fail.
The consequences in many cases are no less than tragic. The time it takes to go from identifying a gene to developing a drug currently stands at 17 years — forever, for people suffering from disease.